OKYO Pharma Limited(OKYO)

Biotechnology · London, GL

$1.46-0.01 (-0.68%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T21:57:44.308Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:57:44.308Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 1.46
Unrounded diluted TTM EPS · period ending 2026-03-31: N/A

FMP input reference: fae3dac89f6aae568c3e1e6131ec6a0b9ed594063ed7dd46d2bf25dadf8b5230

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

OKYO PE Ratio Metrics

PE RATIO

N/A

OKYO Competitors' PE Ratio

OKYO

OKYO Pharma Limited

Current

Market Cap

$56.02M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs OKYO

Market Cap

$55.25M

PE Ratio

N/A

TTM Avg

2.27

3Y Avg

2.27

5Y Avg

2.27

CNTB

Connect Biopharma Holdings Limited

vs OKYO

Market Cap

$57.01M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TLPH

Talphera, Inc.

vs OKYO

Market Cap

$57.61M

PE Ratio

N/A

TTM Avg

0.43

3Y Avg

0.43

5Y Avg

0.43

BOLD

Boundless Bio, Inc.

vs OKYO

Market Cap

$57.76M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs OKYO

Market Cap

$54.14M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KLRS

Kalaris Therapeutics Inc

vs OKYO

Market Cap

$58.06M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INKT

MiNK Therapeutics, Inc.

vs OKYO

Market Cap

$58.29M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs OKYO

Market Cap

$53.70M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACET

Adicet Bio, Inc.

vs OKYO

Market Cap

$58.43M

PE Ratio

N/A

TTM Avg

110.41

3Y Avg

110.41

5Y Avg

110.41

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
OKYO Pharma Limited (OKYO)	$56.02M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$55.25M	N/A	2.27	2.27	2.27
Connect Biopharma Holdings Limited (CNTB)vs ›	$57.01M	N/A	N/A	N/A	N/A
Talphera, Inc. (TLPH)vs ›	$57.61M	N/A	0.43	0.43	0.43
Boundless Bio, Inc. (BOLD)vs ›	$57.76M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$54.14M	N/A	N/A	N/A	N/A
Kalaris Therapeutics Inc (KLRS)vs ›	$58.06M	N/A	N/A	N/A	N/A
MiNK Therapeutics, Inc. (INKT)vs ›	$58.29M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$53.70M	N/A	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$58.43M	N/A	110.41	110.41	110.41

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$1.46

Forward EPS (Est.)

$-0.13

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

OKYO PE Ratio Metrics

OKYO Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics